|
HS Code |
307852 |
| Name | Domperidone Maleate |
| Chemical Formula | C22H25ClN2O5.C4H4O4 |
| Molecular Weight | 569.04 g/mol |
| Appearance | White to off-white powder |
| Solubility | Slightly soluble in water, freely soluble in methanol |
| Storage Conditions | Store below 25°C, protect from light and moisture |
| Cas Number | 99497-03-7 |
| Therapeutic Class | Prokinetic and antiemetic |
| Mechanism Of Action | Dopamine D2 receptor antagonist |
| Indications | Used for nausea, vomiting, and gastrointestinal motility disorders |
As an accredited Domperidone Maleate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Domperidone Maleate, 100g, packed in a sealed amber glass bottle with tamper-evident cap, labeled with hazardous and storage information. |
| Shipping | **Domperidone Maleate** is shipped in airtight, moisture-resistant containers to preserve stability. Packaging complies with regulatory standards for pharmaceuticals. The shipment includes appropriate labeling, safety data sheets, and documentation. Temperature and humidity control may be implemented to ensure product integrity. Handle with protective equipment, following hazardous material guidelines during transport and storage. |
| Storage | Domperidone Maleate should be stored in a tightly closed container, protected from light and moisture. Keep it at a temperature below 25°C (77°F), away from heat sources and incompatible substances. Ensure proper ventilation in the storage area, and keep out of reach of children. Follow local regulations for storage and handling of pharmaceuticals to maintain its stability and efficacy. |
|
Purity 99%: Domperidone Maleate with 99% purity is used in pharmaceutical tablet formulations, where high purity ensures consistent therapeutic efficacy. Melting Point 242°C: Domperidone Maleate with a melting point of 242°C is used in oral solid dosage manufacturing, where thermal stability during processing is maintained. Particle Size <10 µm: Domperidone Maleate with particle size less than 10 µm is used in rapid-release capsule preparations, where fine particle distribution enhances dissolution rate. Stability at 40°C: Domperidone Maleate stable at 40°C is used in long-term storage applications, where chemical integrity during shelf life is preserved. Moisture Content <0.5%: Domperidone Maleate with moisture content below 0.5% is used in film-coated tablet production, where low moisture prevents degradation and ensures product quality. Assay 98-102%: Domperidone Maleate with an assay range of 98-102% is used in injectable suspension formulations, where precise content uniformity assures accurate dosing. Residue on Ignition <0.1%: Domperidone Maleate with residue on ignition less than 0.1% is used in parenteral solutions, where minimal inorganic content improves patient safety. |
Competitive Domperidone Maleate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Any time gut discomfort disrupts daily life, searching for a solution often leads to a maze of names, promises, and pill bottles. Stomach bloating, feeling nauseous on an empty stomach, or a sense of heaviness after a meal are more than everyday nuisances for many. I’ve watched people reach for antacids, peppermint, or ginger tea and still spend hours feeling pinned down by discomfort. That’s where medications like Domperidone Maleate find their place—purpose-built to target the root of sluggish digestion rather than just masking the symptoms. It doesn’t attempt to do everything, but it carves out a crucial space for anyone who struggles with slow stomach emptying or who feels regularly uncomfortable after eating.
I first encountered Domperidone Maleate when a friend’s father, recovering from surgery, couldn’t hold down meals. Doctors explained how this medicine wasn’t there to offer generic relief but to work on the digestive system’s natural rhythm. The experience stuck with me. Domperidone Maleate belongs to a class of medicines called dopamine antagonists. Its real job is to help food move out of the stomach more smoothly. Food doesn’t just sit there: the body finishes its business and you get back to real life, not waiting on the sidelines for normalcy to return. This puts Domperidone Maleate in a league above simple antacids or peppermint oils, which primarily relieve symptoms like heartburn or mild queasiness. It goes for the source—slow stomach muscles—and gives them a much-needed nudge.
Domperidone Maleate stands out for the way it meddles as little as possible with the brain. Compared to many medications in the same family, it largely skips past the blood-brain barrier. That reduces the chance of the drowsiness and fatigue that often come with older anti-nausea drugs. For people with jobs to do, kids to pick up, or meals to make, minimal side effects aren’t a luxury; they’re a cornerstone of getting on with daily responsibilities. In terms of molecular structure, its maleate salt form makes it stable—important for shelf life and consistency. Many liquid medications require refrigeration or don’t travel well, but as a white or almost white powder, Domperidone Maleate keeps its character without dramatic changes from light or temperature.
Doctors and patients alike look out for medications with a predictable effect. From batch to batch, Domperidone Maleate’s model underscores purity and consistency. Small differences in formulation can mean unpredictable results from one bottle to the next, but the careful selection of the maleate salt reduces those variables. One less thing to worry about in an already complicated medical journey.
I think of the busy parents woken up by a sick child, the elderly struggling to digest a normal dinner, and the cancer patient whose treatments make nausea an everyday battle. These aren’t problems solved by novelty supplements or folk remedies but by a medicine whose targeted purpose brings real relief. Domperidone Maleate takes its place on the pharmacy shelf because it gives the digestive tract a helping hand without causing a cascade of other issues, like weighty sedation or confusion. For those whose medications often bring more side effects than solutions, this makes a difference.
Use goes beyond just easing an upset stomach. For those affected by diabetic gastroparesis, where nerve damage causes slow stomach emptying, life feels like an endless wait. Eating becomes a negotiation. Domperidone Maleate is designed exactly for this scenario. By blocking dopamine’s action on the stomach muscle, it sharpens the pace and helps food move along. This isn’t a blanket fix. It doesn’t suit everyone and every situation, but it finds its mark among people whose misery doesn’t fade just by avoiding spicy foods or eating slowly.
What’s more, Domperidone Maleate is different from many older motility agents. It avoids the kinds of nervous system side effects that leave people feeling groggy, anxious, or unable to focus for the day. The ability to take a medication and keep your wits about you ranks high on the list of what makes for a dependable therapy.
Trust in a medication grows from both clinical results and a deep sense of safety. Each manufacturing batch of Domperidone Maleate aims for a narrow range in purity—usually well over 99%—ensuring contaminant levels remain tight and consistent. Pharmaceutical factories maintain these standards not out of bureaucratic rule-following, but because drifting outside these numbers means unpredictable outcomes. The medicine isn’t available in every flavor, form, or dose under the sun, but the standard tablet doses tend to hover around the 10 mg mark. Liquids can be prepared, but the bulk of users find reliability and simplicity in a pill that dissolves in the stomach without elaborate steps or mixing.
The medicine’s shelf life usually stretches over two years from the date of manufacturer’s release when stored in a dry, room-temperature environment. This means having reliable stock on hand in clinics without scrambling for refrigeration space or racing against expiration. For doctors in rural settings or countries with wavering electricity, stability means more than convenience; it means a patient doesn’t miss out on a needed medication just because logistics didn’t line up.
It’s not just about the powdered ingredient. Tablet manufacturing standards call for binders and fillers chosen specifically for their low reactivity and digestibility. Chemists don’t take shortcuts here, as poor choices mean absorption drops, doses fluctuate, or allergens sneak in. For example, choosing microcrystalline cellulose or lactose as a filler is less about saving money than preserving the ways the tablet behaves inside the digestive tract.
It helps to remember that not all medications meant to settle the stomach work the same way. Many familiar over-the-counter drugs rely principally on soaking up acid or numbing the digestive lining. Proton pump inhibitors shut off acid pumps, but sometimes at the cost of long-term issues like loss of bone density or increased risk of infections. Metoclopramide, a cousin in the prokinetic drug family, crosses into the brain and often brings with it a risk for movement disorders—or what neurologists call “extrapyramidal symptoms.” I’ve heard stories of patients who had no idea these risks existed until new symptoms turned up months into treatment. No one wants to solve a stomach problem only to trade it for a tremor, anxiety, or trouble sleeping.
Domperidone Maleate by design cuts down these risks. Its structure resists slipping across the blood-brain barrier, so movement disorders or emotional side effects remain unlikely. For older adults or those on many different medicines, this smaller likelihood of unintended symptoms keeps life manageable. And with fewer interactions compared to antipsychotics or antidepressants, doctors can factor Domperidone Maleate into care plans without wholesale changes to other prescriptions.
While Domperidone Maleate isn’t suitable for every patient group—the medication has limits, such as in those with existing heart rhythm disturbances—it draws a clear line compared to motility agents that carry bigger baggage. Choices come down to who’s sitting in the exam room: history of tremors, a day filled with important tasks, or juggling several prescriptions all at once. The right medication should adapt to these realities and not ask for unreasonable trade-offs.
Doctors prescribing Domperidone Maleate build their trust on rigorous studies spanning many years. International guidelines demand ongoing reviews of any emerging side effects. In sensible doses under close guidance, Domperidone Maleate keeps major cardiac risks rare, yet headlines from isolated incidents have led regulators to recommend maximum daily amounts and shorter courses for specific groups. Out of every 10,000 patients, only a handful run into heart rhythm problems, and most already have underlying risks.
Yet, the rules don’t spring up out of caution alone. Pharmaceuticals command respect because their production isn’t left to chance. Every batch leaves the factory with supporting documentation, tracking everything from impurity levels to particle size. Pharmacists keep records because patients deserve more than a promise—they get performance histories for each brand and batch number. Inspections ensure labeling remains accurate, too, since even small errors could result in wrong doses or misunderstandings at the pharmacy counter. The importance of this diligence became clear to me after speaking with hospital pharmacists who spend hours cross-checking drug labels against patient charts, an unseen wall against errors that rarely get reported unless things go wrong.
There’s a gap between what is scientifically possible and what everyday patients receive. Cost, as always, creates headwinds. Domperidone Maleate, though off-patent in many places, varies in price depending on local manufacturing, import regulations, and insurance coverage. In some countries, people pay pocket change for a week’s supply; elsewhere, they must budget or skip doses because subsidies don’t cover the medicine.
Long-standing debates about generic production, local manufacturing, and distribution need more real voices—patients, pharmacists, and primary doctors who see the consequences of interrupted treatment. One practical step involves increasing local manufacturing with clear quality oversight. Countries choosing to invest in domestic pharmaceutical production can negotiate better prices while making sure medicines remain true to their chemical promises. I’ve spoken with clinicians in resource-limited settings who rely on just-in-time deliveries and must decide who gets the limited stock. Strengthening regional supply chains means those emergency choices happen less often.
Ease of use further cements Domperidone Maleate’s value. A patient able to take a single tablet before meals—rather than combining two or three remedies or mixing liquid suspensions—follows therapy more faithfully. This sort of consistency builds results, reduces wasted doses, and ultimately keeps symptoms at bay. Cutting out barriers to access is as much about sensible packaging and instructions as about sticker price.
Doctors and pharmacists play key roles beyond simply signing prescriptions. They educate about the correct timing and frequency of Domperidone Maleate, reviewing patient history for possible heart risks, and clarifying what side effects deserve immediate reporting. Direct pharmacist-patient relationships matter—a face-to-face conversation often means the difference between ongoing success and a quietly abandoned treatment regimen. I’ve encountered parents of children with chronic stomach issues who rely on under-the-radar support groups, trading experiences about what timing, meal choices, or symptom tracking works best with Domperidone Maleate in the mix.
Packaging design makes a difference, as many older adults face trouble opening child-proof bottles or reading small instructions. Enlarging labels, color-coding pill bottles for morning or evening use, and reducing unnecessary packaging waste all lend themselves to better adherence. The simplest changes, like adding a scored tablet that eases splitting, can reflect real sensitivity to patient routines. Studies show that follow-through on medication depend on ease of use, plain language, and visual clarity nearly as much as molecular effectiveness.
Ongoing studies into the long-term effects of Domperidone Maleate will keep shaping its clinical recommendations. Regulators and research teams constantly look for unexpected patterns where benefits no longer clearly outweigh risks. This vigilance keeps patients safe and informs new guidelines for heart screening or dose adjustment. Year by year, data on rare complications or new uses accumulates, refining practice and steering future versions of the product toward ever tighter safety margins.
Prevention is tied to informed use. Medical societies recommend that doctors and patients alike stay current on updates. New warnings about drug interactions or revised dose instructions matter. In busy clinics, easy-to-update training modules for staff help close the gap. For patients, pharmacy counseling sessions or community health seminars offer chances to ask questions. In my own experience volunteering with chronic illness support groups, I’ve seen that peer-to-peer teaching often succeeds where top-down announcements drown in noise; people trust learning from others who’ve walked the same road.
Innovation also remains a tangible goal. Researchers look into new delivery mechanisms for Domperidone Maleate, including dissolvable strips or rapid-dissolve tablets that suit children or people unable to swallow pills. Investment in research drives future improvements, always balanced by the need for affordability and availability. Small steps like these mean more patients can benefit with fewer tradeoffs—an outcome that echoes the actual daily struggles of living with digestive conditions.
Domperidone Maleate crosses the laboratory threshold into millions of kitchens, lunchrooms, and homes where relief from digestive symptoms brings much more than comfort. It means showing up for work, eating dinner with family without dreading the aftermath, seeing a movie without plotting restroom escapes. The unique blend of targeted action, predictable results, and relative safety shape its place in modern medicine, not as a cure-all, but as a trusted tool where older options have let people down.
Discussions over pharmaceutical safety, cost, and access sometimes drown out the everyday power of a treatment like Domperidone Maleate. The real-world perspective centers on the lived experiences of patients: mothers juggling sick kids, seniors hoping for peaceful meals, young adults navigating unpredictable guts and crowded days. Those stories shape both the future of this drug and the broader field of medications aimed at making daily life work for those wrestling with stomach disorders. The work continues in labs, pharmacies, and communities, reaching for a future where simple solutions line up, side-by-side, with complex ones—grounded in deep knowledge, but built for real life.